PLOD1 and viral infectious disease: LH treatment at 2 μM led to reduced progeny virus production by 4.5, 6.4, and 7.2 logs compared to the DMSO controls for the three viral infection doses (10, 100 and 1,000 TCID50) (Figure 2C), respectively.